The pioneering team
Founded in 2007, SetPoint Medical started exploring the scientific principles of stimulating the vagus nerve for treatment of autoimmune diseases based on Dr. Kevin Tracey’s pioneering discovery of the Inflammatory Reflex.
SetPoint Medical’s revolutionary, miniaturized implant is currently undergoing clinical studies in the United States for Rheumatoid Arthritis under IDE clinical study. In parallel, the company has conducted an additional successful proof-of-concept study in Crohn’s disease as well as promising pre-clinical research in multiple sclerosis.
MURTHY SIMHAMBHATLA, PhD
Chief Executive Officer
Murthy Simhambhatla was formerly the President and Chief Executive Officer of Evolus, a medical aesthetics company with a lead biologic drug, DWP-450, which he led towards an IPO in 2018. Prior to Evolus, Dr. Simhambhatla was a Senior Vice President at Abbott Laboratories and President of Abbott Medical Optics, a $1B-plus global ophthalmic business focused on cataract and refractive surgery.
DAVID CHERNOFF, MD
Chief Medical Officer
David Chernoff has 25 years of molecular diagnostics and biopharmaceutical experience and has served as a translational medicine consultant to more than 40 biopharma and device companies. He has held chief medical officer posts with a number of venture capital backed diagnostic and therapeutic companies. He was formerly VP of Corp Technology at Elan Pharma and Medical Director at Chiron Corp.
Vice President of Product Development
Bill Calle was formerly the Sr. Director of Software at Advanced Bionics. He has over 30 years of experience in the integration and productization of complex electromechanical and software systems including in aerospace, entertainment, robotics, telecom and active implantables.
Vice President of Clinical Affairs
Amy Derosier brings over 20 years of experience in clinical affairs for multiple early-stage medical device companies, including Torax Medical (acquired by Johnson & Johnson), where she built a significant portfolio of clinical evidence to support PMA, HDE, and CE Mark regulatory approvals as well as commercialization.
Vice President of Operations
John Long joined SetPoint Medical in 2015. He has held several senior operations leadership positions over the last 15 year including leading L.A. Turbine Corporation as COO.
Vice President of Regulatory Affairs
Alexis Dineen has over 30 years of experience in driving the regulatory affairs process for medical device start-up companies. Since starting her career at Target Therapeutics, she has led regulatory processes for Conceptus, EMBOL-X and the Foundry. She has also served as Acting VP of Regulatory for numerous companies, including most recently for AEGEA Medical (now CooperSurgical), EBR Systems and Evalve.
Vice President of Marketing
Ankit Shah has more than a decade of experience developing and commercializing innovative medical technology. He was a founding member of the commercialization team at Intersect ENT (NASDAQ: XENT) and held positions at Outset Medical, Medtronic, SV Health Investors and the FDA.
Yaakov Levine, PhD
Vice President of Research
Yaakov Levine holds a PhD in biomedical engineering and has focused on developing non-pharmacologic treatments for chronic diseases in both academic and industry settings. He has been advancing bioelectronic medicine for over a decade.
Director of Program Management
Dan Ward has over 15 years of medical device experience, holding a broad range of roles in program and product management, operations, quality, and engineering. He brings to SetPoint extensive problem solving and leadership experience needed to develop Class III devices with cross-functional, international, and multi-site teams.
Vice President of Quality
Kevin Wilkin was formerly Senior Manager of Quality Assurance at Palyon Medical. His prior experience includes work in Quality Assurance and Development as a Mechanical Engineer for Bioness, TriMed, and Second Sight. He has over 15 years of experience in the medical device industry with the last 10+ years being in Quality Assurance management positions.
BOARD OF DIRECTORS
Allan Will, Chairman of the Board
Hank Plain, Morgenthaler Ventures
Josh Makower, New Enterprise Associates
Juan-Pablo Mas, Action Potential Venture Capital
Murthy Simhambhatla, SetPoint Medical
Steve Winick, Topspin Partners
Zack Scott, Norwest Venture Partners
CAUTION – Investigational device. Limited by United States law to investigational use.